| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/18/1995 | US5434133 CNP analog peptides and their use |
| 07/18/1995 | CA1336326C Microbeads of diltiazem, a process for their manufacture and a sustained-release pharmaceutical composition containing them |
| 07/13/1995 | WO1995018856A1 Vertebrate embryonic pattern-inducing hedgehog-like proteins |
| 07/13/1995 | WO1995018826A2 Purified primate ctla-8 antigens and related reagents |
| 07/13/1995 | WO1995018824A1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
| 07/13/1995 | WO1995018820A1 Monomeric diols and phosphate linked oligomers formed therefrom |
| 07/13/1995 | WO1995018819A1 Ligand that binds fas antigen |
| 07/13/1995 | WO1995018815A1 Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine |
| 07/13/1995 | WO1995018804A1 Water soluble onium salt of taxo-diterpenoid |
| 07/13/1995 | WO1995018799A1 Phenyl heterocycles as cox-2 inhibitors |
| 07/13/1995 | WO1995018797A1 Novel serine protease inhibitors: derivatives of isothiazolidin-3-one-1,1 dioxide and 3-oxo-1,2,5-thiadiazolidine-1,1-dioxide |
| 07/13/1995 | WO1995018793A1 Novel heterocyclic compounds |
| 07/13/1995 | WO1995018792A1 Pyrrolidine-containing monomers and oligomers |
| 07/13/1995 | WO1995018625A1 The composition containing snapping turtle and tortoise, the preparation and the use thereof |
| 07/13/1995 | WO1995018623A1 Oligomeric compounds having nitrogen-containing linkages |
| 07/13/1995 | WO1995018622A1 Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents |
| 07/13/1995 | WO1995018619A1 Bicyclic fibrinogen antagonists |
| 07/13/1995 | WO1995018617A1 1-aminoindan derivatives and compositions thereof |
| 07/13/1995 | WO1995018616A2 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/nmda receptor |
| 07/13/1995 | WO1995018615A1 A method of treating neurogenic inflammation |
| 07/13/1995 | WO1995018614A1 Method for treatment of obesity using prolactin modulators and diet |
| 07/13/1995 | WO1995018610A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 07/13/1995 | WO1995018607A1 Pharmaceutical compositions |
| 07/13/1995 | WO1995018606A1 Curcumin, analogues of curcumin and novel uses thereof |
| 07/13/1995 | WO1995016035A3 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
| 07/13/1995 | CA2181082A1 Oligomeric compounds having nitrogen-containing linkages |
| 07/13/1995 | CA2180651A1 Phenyl heterocycles as cox-2 inhibitors |
| 07/13/1995 | CA2180477A1 Curcumin, analogues of curcumin and novel uses thereof |
| 07/13/1995 | CA2180446A1 Pharmaceutical compositions |
| 07/13/1995 | CA2180340A1 1,4-benzoxazine-2-acetic acid compound, process for producing the same, and use thereof |
| 07/13/1995 | CA2180239A1 A method of treating neurogenic inflammation |
| 07/13/1995 | CA2180238A1 Novel heterocyclic compounds |
| 07/13/1995 | CA2180123A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 07/13/1995 | CA2180122A1 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the usethereof as antagonists for the glycine/nmda receptor |
| 07/13/1995 | CA2179913A1 Novel serine protease inhibitors: derivatives of isothiazolidin-3-one-1,1 dioxide and 3-oxo-1,2,5-thiadiazolidine-1,1-dioxide |
| 07/13/1995 | CA2139391A1 Azepanes and homologs thereof |
| 07/12/1995 | EP0662481A1 Spiro piperidines and homologs promote release of growth hormone |
| 07/12/1995 | EP0662473A1 2-Oxindole derivatives as tyrosine kinase inhibitors |
| 07/12/1995 | EP0662319A1 Cosmetic and/or dermatologic composition for the treatment of aging containing ceramides, and its use |
| 07/12/1995 | EP0662133A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 07/12/1995 | EP0662130A1 A method of producing hepatocyte growth factor and a cell line |
| 07/12/1995 | EP0662087A1 Retinal pigmented epithelium derived neurotrophic factor |
| 07/12/1995 | EP0662075A1 Prostaglandin analog for treating osteoporosis |
| 07/12/1995 | EP0661992A1 Pharmaceutical formulations of interleukin-1 inhibitors |
| 07/12/1995 | EP0661991A1 Methods for treating renin-related disorders with amylin antagonists |
| 07/12/1995 | EP0661990A1 Method for systemic treatment of catabolic conditions and systemic tissue injury |
| 07/12/1995 | EP0661982A1 Method for antagonizing inositol 1,4,5-triphosphate |
| 07/12/1995 | EP0661978A1 Arylmethylphosphonates and phosphonic acids useful as anti-inflammatory agents |
| 07/12/1995 | EP0550458B1 Bone growth stimulator |
| 07/12/1995 | EP0526537B1 5-benzyl barbiturate derivatives |
| 07/12/1995 | EP0463139B1 2,13-disubstituted ergolins, their preparation and their use in drugs |
| 07/12/1995 | CN1104901A Pill for blackening hair and strengthening body |
| 07/11/1995 | US5432192 Antihistamines |
| 07/11/1995 | US5432190 Pharmaceutical compositions containing triazoles and method of treating estrogen-dependent diseases |
| 07/11/1995 | US5432181 Substituted heteroaryl analogs of 4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
| 07/11/1995 | US5432178 Amidinophenol derivatives |
| 07/11/1995 | US5432175 Pyridine and pyridine N-oxide derivatives of diaryl methyl piperidines or piperazines, and compositions and methods of use thereof |
| 07/11/1995 | US5432171 Water soluble texaphyrin metal complexes for viral deactivation |
| 07/11/1995 | US5432168 Method of treatment of hormone-unresponsive metastatic prostate cancer |
| 07/11/1995 | US5432167 Hyaluronic acid |
| 07/11/1995 | US5432159 N-(α-substituted-pyridinyl)carbonyl dipeptide antihypertensive agents |
| 07/11/1995 | US5432156 Therapeutic agent for digestive tract diseases |
| 07/11/1995 | US5431925 Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression |
| 07/11/1995 | US5431920 Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents |
| 07/11/1995 | CA2139018A1 Cosmetic and/or dermatologic composition for the treatment of aging comprising ceramids, and its use |
| 07/11/1995 | CA1336287C Selective serotonin uptake inhibitors |
| 07/08/1995 | CA2139612A1 Novel inhibitor |
| 07/06/1995 | WO1995018228A1 Human circulating cytokine cc-1 |
| 07/06/1995 | WO1995018221A1 Gene coding for adseverins |
| 07/06/1995 | WO1995018141A1 Medicinal composition for bone resorption inhibition and osteogenesis acceleration |
| 07/06/1995 | WO1995018132A1 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists |
| 07/06/1995 | WO1995018131A1 New ginkgolide derivatives and a process for preparing them |
| 07/06/1995 | WO1995018124A1 Substituted morpholine derivatives and their use as therapeutic agents |
| 07/06/1995 | WO1995018105A1 1,3-dihydroindol-2-one derivatives substituted in position 3 by a nitrogen group as vasopressin and/or ocytocine agonists and/or antagonists |
| 07/06/1995 | WO1995017910A2 Paramagnetic diagnostic formulations and their method of use |
| 07/06/1995 | WO1995017907A1 Methods and compositions for inhibiting thrombogenesis |
| 07/06/1995 | WO1995017904A2 Botulinum toxins for treating various disorders and associated pain |
| 07/06/1995 | WO1995017903A1 Modular design and synthesis of oxazolone-derived molecules |
| 07/06/1995 | WO1995017902A1 Use of a strain of the fungus fusarium as a substance producer and a preparation based on it with adaptogenic and immunomodulating properties |
| 07/06/1995 | WO1995017901A1 Methods and compositions for the treatment of a host with a cellular proliferative disease |
| 07/06/1995 | WO1995017888A1 Phenylmethyl hexanamides, and the use thereof |
| 07/06/1995 | WO1995017887A1 Method of treatment of hormone-unresponsive metastatic prostate cancer |
| 07/06/1995 | WO1995017876A2 2,4-disulphophenyl butylnitrone, its salts, and their use as pharmaceutical spintraps |
| 07/06/1995 | WO1995016435A3 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent |
| 07/06/1995 | CA2682117A1 The use of the neurotoxic component of a botulinum toxin for the treatment of a facial disease, disorder or condition |
| 07/06/1995 | CA2180260A1 Methods and compositions for the treatment of a host with a cellular proliferative disease |
| 07/06/1995 | CA2180140A1 Methods and compositions for inhibiting thrombogenesis |
| 07/06/1995 | CA2180014A1 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists |
| 07/06/1995 | CA2179638A1 Human circulating cytokine cc-1 |
| 07/06/1995 | CA2177736A1 New ginkgolide derivatives and a process for preparing them |
| 07/05/1995 | EP0661269A1 Substituted heterocyclic carboxylic acid amides, their preparation and their use as medicaments |
| 07/05/1995 | EP0661264A1 Substituted benzenesulfonylureas and -thioureas as antiarrhythmics |
| 07/05/1995 | EP0661261A1 Phenyl or phenylalkyl substituted naphtalene derivatives having retinoid-like activity as well as anti-tumor activities |
| 07/05/1995 | EP0661259A1 Substituted (5,6)-dihydronaphthalenyl compounds having retinoid-like activity |
| 07/05/1995 | EP0661038A1 Depigmentation composition for the simultaneous treatment of the superficial skinlayers and the deep skinlayers |
| 07/05/1995 | EP0660936A1 Up-converting reporters for biological and other assays using laser excitation techniques |
| 07/05/1995 | EP0660836A1 Tricyclic derivatives of the thienodiazocine and thienothiadiazocine classes of compounds |
| 07/05/1995 | EP0660834A1 Fullerene derivatives, method of synthesizing them and their use |
| 07/05/1995 | EP0660833A1 3,3'-DISUBSTITUTED-1,3-DIHYDRO-2H-PYRROLO 2,3-b]HETEROCYCLIC-2-ONE USEFUL IN THE TREATMENT OF COGNITIVE DISORDERS OF MAN |
| 07/05/1995 | EP0660832A1 Serotonin receptor agents |